MolPort-001-783-406

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

21 API Suppliers, 10 USDMF, 7 CEP/COS, 1 JDMF, 6 EU WC, 3 KDMF, 7 NDC API, 11 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

14 Drugs in Development

14 Drugs in Development

FINISHED DOSAGE FORMULATIONS

40 FDF Dossiers, 17 FDA Orange Book, 6 Europe, 3 Canada, 1 Australia, 5 South Africa, 8 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 6MG/ML, TABLET;ORAL - 2MG

RELATED EXCIPIENT COMPANIES

3 SPI Pharma, 2 Seqens, 2 DKSH, 6 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 3 Actylis, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 BASF, 1 Clariant, 10 Corel Pharma Chem, 1 DFE Pharma, 1 Finar, 3 Gangwal Chemicals, 4 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 19 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 7 Microlex e.U, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pluviaendo, 1 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 8 Roquette, 7 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 The Dow Chemical Company, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

43 Coating Systems & Additives, 28 Fillers, Diluents & Binders, 21 Controlled & Modified Release, 12 Direct Compression, 9 Thickeners and Stabilizers, 9 Film Formers & Plasticizers, 8 Topical, 8 Lubricants & Glidants, 8 Co-Processed Excipients, 5 Granulation, 5 Taste Masking, 5 Solubilizers, 5 Empty Capsules, 5 Disintegrants & Superdisintegrants, 4 Coloring Agents, 4 Chewable & Orodispersible Aids, 4 Vegetarian Capsules, 3 API Stability Enhancers, 3 Parenteral, 2 Emulsifying Agents, 2 Rheology Modifiers, 1 Surfactant & Foaming Agents